肿瘤来源微粒在肿瘤发生发展及诊断治疗中的作用

doi:10.11904/j.issn.1002-3070.2015.04.018

Abstract

Abstract: Tumor derived microparticles are released by activated or apoptotic tumor cells.They are extracellular vesicles which are 0.1~1.0μm in diameters.Tumor derived microparticles carry abundant bioactive molecules,such as nucleic acids and proteins,which resemble that of the parental cell.In this review,we summarize the role of tumor derived microparticles in the occurrence,development,diagnosis and treatment of tumor.

Key words: Tumor derived microparticles, Tumor, Diagnosis, Progress

CLC Number:

R73-3

CHEN Xiaotong,ZHANG Yingmei,ZHOU Jin. The role of tumor derived microparticles in the occurrence,development and diagnosis of tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(4): 368-371.

References

1 Morel O,Jesel L,Freyssinet JM,et al.Cellular mechanisms underlying the formation of circulating microparticles[J].Arterioscler Thromb Vasc Biol,2011,31(1):15-26.
2 Voloshin T,Fremder E,Shaked Y,et al.Small but mighty:microparticles as mediators of tumor progression[J].Cancer Microenviron,2014,7(1-2):11-21.
3 Hou J,Fu Y,Zhou J,et al.Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of storedplatelets[J].Vox Sang,2011,100(2):187-195.
4 Roseblade A,Luk F,Rawling T,et al.Cell-derived microparticles:new targets in the therapeutic management of disease[J].J Pharm Pharm Sci,2013,16(2):238-253.
5 Falanga A,Tartari CJ,Marchetti M.Microparticles in tumor progression[J].Thromb Res,2012,129(Suppl 1):S132-136.
6 Wieckowski EU,Visus C,Szajnik M,et al.Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes[J].J Immunol,2009,183(6):3720-3730.
7 Al-Nedawi K,Meehan B,Kerbel RS,et al.Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR[J].Proc Natl Acad Sci USA,2009,106(10):3794-3799.
8 Balaj L,Lessard R,Dai L,et al.Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences[J].Nat Commun,2011,2:180-199.
9 Jaiswal R,Luk F,Dalla PV,et al.Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells[J].PLoS One,2013,8(4):e61515.
10 Gong J,Jaiswal R,Mathys JM,et al.Microparticles and their emerging role in cancer multidrug resistance[J].Cancer Treat Rev,2012,38(3):226-234.
11 Grange C,Tapparo M,Collino F,et al.Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche[J].Cancer Res,2011,71(15):5346-5356.
12 Sheu JJ,Lee FY,Wallace CG,et al.Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis,blood flow and ischemic recovery in rat critical limb ischemia[J].J Transl Med,2015,13:59.
13 Martinez MC1,Andriantsitohaina R.Microparticles in angiogenesis:therapeutic potential[J].Circ Res,2011,109(1):110-119.
14 Echrish HH,Xiao Y,Madden LA,et al.Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activity[J].Thromb Res,2014,134(2):479-487.
15 Fremder E,Munster M,Aharon A,et al.Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing:a process regulated by osteopontin[J].Int J Cancer,2014,135(2):270-281.
16 Munster M,Fremder E,Miller V,et al.Anti-VEGF-A affects the angiogenic properties of tumor-derived microparticles[J].PLoS One,2014,9(4):e95983.
17 Dieh P,Fricke A,Sander L,et al.Microparticles:major transport vehicles for distinct microRNAs in circulation[J].Cardiovasc Res,2012,93(4):633-644.
18 Angelucci A,D′Ascenzo S,Festuccia C,et al.Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines[J].Clin Exp Metastasis,2000,18(2):163-170.
19 Schroder WA,Major LD,Le TT,et al.Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis[J].Cancer Med,2014,3(3):500-513.
20 Pasquier J,Thawadi HA,Ghiabi P,et al.Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation[J].Cancer Microenviron,2014,7(1-2):41-59.
21 杨桐树,李文辉,孙喜文,等.血清五种肿瘤标志物联合检测在肺癌诊断中的意义[J].实用肿瘤学杂志,2010,24(3):243-246.
22 Reynés G,Vila V,Fleitas T,et al.Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma:prognostic value[J].PLoS One,2013,8(7):e69034.
23 Toth B,Nieuwland R,Liebhardt S,et al.Circulating microparticles in breast cancer patients:a comparative analysis with established biomarkers[J].Anticancer Res,2008,28(2A):1107-1112.

[1]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[2]	LIU Yishu,QU Guofan. Progress in long-chain non-coding RNA in osteosarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 266-270.
[3]	HOU Yuxue,LI Xiaoli. The research progress of Wnt7a and malignant tumors,and its relationship [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 271-275.
[4]	LI Shan,ZHAO Chunbo,QIAO Wenbo. Progress in the application of intraoperative radiotherapy in pancreatic cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 280-283.
[5]	XU Hui, LI Xi, ZHOU Chunshui. Screening of lung cancer tumor-associated suppressor genes using shRNA library targeting human transcriptome [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 97-102.
[6]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.
[7]	TONG Guanghai, TIAN Yang, WU Huaxing. Application of lipidomics in colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 179-192.
[8]	YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.
[9]	DING Jiexian, ZHANG Jin, CHEN Yonggang, WANG Xingwen, WANG Shuanke. Progress in Wnt signaling pathway and tumorigenesis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 73-77.
[10]	TIAN Yang, WU Huaxing. Clinical application of ultra-fine nasal endoscopy in digestive tract stenosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 550-554.
[11]	KAN Jun, ZHOU Daihan, ZHANG Enxin. Research progress in tumor with cardiovascular disease [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 558-561.
[12]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[13]	WANG Peng, ZHOU Haitao, LIANG Jianwei, ZHOU Zhixiang. Misdiagnosis of mesenteric fibromatosis as recurrence after radical resection of rectal cancer:A report of one case with literature review [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 442-444.
[14]	LI Yue, XU Ke, HAN Zengxiang, SUN Min, FAN Guohua, ZHANG Yong. Advances in the role of tumor-associated macrophage in colon cancer and targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 450-454.
[15]	WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.

The role of tumor derived microparticles in the occurrence,development and diagnosis of tumor

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments